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Abstract
Purpose The epidemiology and risk factors for develop-
mental dysplasia of the hip (DDH) are still being refined.
We investigated the local epidemiology of DDH in order to
define incidence, identify risk factors, and refine our policy
on selective ultrasound screening.
Methods With a cohort study design, data were prospec-
tively recorded on all live births in our region from January
1998 to December 2008. We compared data on babies
treated for DDH with data for all other children. Crude
odds ratios (ORs) were calculated to identify potential risk
factors. Logistic regression was then used to control for
interactions between variables.
Results There were 182 children born with DDH (with a
total of 245 dysplastic hips) and 37,051 without. The
incidence was 4.9 per 1000 live births. Female sex (ad-
justed OR 7.2, 95% confidence interval [CI] 4.6–11.2),
breech presentation (adjusted OR 24.3, 95% CI 13.1–44.9),
positive family history (adjusted OR 15.9, 95% CI
11.0–22.9) and first or second pregnancy (adjusted OR 1.8,
95% CI 1.5–2.3) were confirmed as risk factors
(p\ 0.001). In addition, there was an increased risk with
vaginal delivery (adjusted OR 2.7, 1.6–4.5, p\ 0.001) and
post-maturity (OR 1.7, 1.2–2.4, p\ 0.002).
Conclusions One in 200 children born within our region
requires treatment for DDH. Using both established and
novel risk factors, we can potentially calculate an indi-
vidual child’s risk. Our findings may contribute to the
debate regarding selective versus universal ultrasound
screening.
Level of Evidence Prognostic Study: Level 1.
Keywords DDH  Epidemiology  New risk factors
Background
Developmental dysplasia of the hip (DDH) is a common
and preventable cause of childhood disability, and forms a
large portion of paediatric orthopaedic practice. It is gen-
erally agreed that late diagnosis (often quoted as diagnosis
after 3 months) leads to a higher chance of needing surgery
and a higher risk of long-term complications [1].
The epidemiology and risk factors for DDH are still
being refined. The incidence in the UK before ultrasound
(US) screening became available was quoted as 1–2 per
1000. Since the advent of selective US screening, which
selectively ultrasounds the hips of babies who are thought
to be at high risk of DDH, estimates of the UK incidence
have increased and range from 5-30 per 1000 [2].
There is consensus that a family history of DDH, breech
presentation, female sex, primiparity and oligohydramnios
increases the risk of a baby having DDH, although only
babies in the first two categories are generally selected for
US screening [3]. There is inconsistency in the literature as
to whether the risk is affected by birth weight, prematurity,
multiple pregnancy, mode of delivery or the presence of
foot deformity [4–6].
We therefore examined the epidemiology of DDH in our
region, with particular attention to risk factors.
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Methods
The catchment region for our centre has a population of
450,000. We analysed this region from January 1998 to
December 2008. The annual birth rate over this period was
3500 per year, with 37,233 live births recorded.
We examined data, prospectively recorded by the senior
author, on all referrals to the regional hip screening clinic
over this 11-year period. The data gathered included
demographic variables, family history, intra-uterine posi-
tion, method of delivery, gestational age at birth, birth
weight, presence of other deformities, oligohydramnios and
other gestational and medical history.
The relevant control group consisted of all other live
births (37,051) in the same region over the same period.
Birth data for the control group were collected prospec-
tively by midwives and recorded on the local Liveslot
database/Stork record. The data collected included all of
the variables collected on those babies referred to the DDH
clinic, with the exception of oligohydramnios and foot
deformities (poorly documented in the control group).
Diagnosis of DDH
The approach to diagnosis of DDH was consistent
throughout this period. An obstetric history was taken,
including risk factors for DDH, breech presentation and
family history. The hips of all the babies were clinically
examined by a junior paediatric doctor on the post-natal
ward and again at 6 weeks by the general practitioner.
The regional DDH service consisted of a ‘one-stop’
neonatal hip clinic providing repeat clinical examination by
an experienced consultant, US and Pavlik harness treat-
ment for babies at risk. If the post-natal examination was
abnormal, babies were referred immediately and seen and
scanned at two weeks after birth. If the examination was
normal but babies had a risk factor, they were seen and
scanned at 5–6 weeks. If the 6-week examination by the
GP was abnormal they were seen within 2 weeks of referral
(7–8 weeks after birth). Treatment was decided on the
basis of a combination of Graf grading on a coronal US
view, and instability on dynamic anterior US [7, 8]. Babies
with Graf 4 hips were placed immediately in a Pavlik
harness and followed up with serial US, as were most Graf
3 hips. Graf 2 hips and Graf 3 hips with minimal decen-
tering were monitored with serial US, with the majority
spontaneously improving. Between 6 and 12 weeks, hips
with persisting grade 2c dysplasia or instability were
treated in harness. At 12 weeks, any baby with persisting
dysplasia of grade 2b was treated. Treatment was escalated
as appropriate based on response to Pavlik harness man-
agement. Whether treated or not, babies with hips of grade
C2a were followed up with US scanning until normality on
US was reached. Radiographs were performed at 1 year for
any baby failing/requiring a greater level of intervention
than Pavlik harness management. Follow-up was only
discontinued if they were normal.
Case definition
Case definition included all decentered or dislocated hips
(Graf III and IV), critical range dysplasia (Graf IIc hips)
that persisted beyond 6 weeks of age, and instability
diagnosed on US that persisted beyond 6 weeks. ‘Late
diagnosis’ was defined as babies presenting after 12 weeks,
in common with several other authors.
Exclusions
Babies with teratological and neuromuscular dysplasia of
the hip were excluded. Babies reviewed at the clinic who
were not born within the regional catchment area were
excluded. Six babies had little or no data recorded from the
referral clinic and were therefore also excluded.
Data handling
The control group data was imported into a spreadsheet and
validated. Births from out of the region were removed.
Duplicate data was removed. Any missing data was
quantified and extraneous data removed. As the DDH
group contained no twins, multiple births were also
removed from the control data.
Free text entries recorded under ‘family history’ box
were scrutinised. Items such as ‘CDH’, ‘DDH’, ‘clicky
hip’, ‘hip dysplasia’, ‘hip dislocation’ and ‘treatment for
infant hip problems’ were given a positive value. Family
history of Perthes disease, slipped upper femoral epiphysis,
hip fractures or infection/septic arthritis of the hip were
given a negative value.
Maternal age was stratified into groups of 5 years and
gestational age was counted in weeks, and counted as
‘post-maturity’ if [38 weeks; all other continuous vari-
ables were treated as such.
Intra-uterine position was recorded at onset of labour
and classified as cephalic, breech or ‘other’, which inclu-
ded transverse position and shoulder dystocia.
The known cases of DDH were found and removed from
the control group, so that individuals were not counted
twice. The agreement between the data sets was checked
(the data relating to babies with suspected DDH recorded
by the referral clinic and data recorded on the Liveslot
database/Stork record) with particular reference to the
potential risk factors. The agreement between the datasets
was extremely high, except in family history, where there
was a 56% agreement. We therefore used family history
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data from the Liveslot database, so any recall bias in the
DDH study group was eliminated.
Statistical analysis
Data were analysed using SPSS. For each variable we
performed univariate analysis, looking at crude odds ratios
(ORs) for DDH, and calculated 95% confidence intervals
and p values. Variables with crude ORs showing signifi-
cance (p\ 0.05) or borderline significance
(0.10[ p[ 0.05) were considered potential risk factors,
and were then re-analysed using logistic regression to
discover and control for interactions and confounding
factors.
Results
Between 1st January 1998 and 31st December 2008, there
were 182 children (245 dysplastic hips) diagnosed with
DDH, and 37,051 other singleton live births from within
the area. There were 159 females with DDH and 23 males.
One hundred and forty-seven children were diagnosed
before 12 weeks while 35 presented later than this. Of 147
children presenting before 12 weeks, 133 were successfully
managed by Pavlik harness alone. Three late presenters
were tested with Pavlik harness management—one was
successful while the other required a higher level of
intervention [8, 9]. The overall incidence of DDH requiring
treatment was therefore 4.9/1000 with a late diagnosis rate
of 0.94/1000 (Fig. 1).
Variables with significant association with DDH
(p\ 0.05) were female sex, breech position, ‘other posi-
tion’ (transverse lie, shoulder dystocia), family history, first
pregnancy, second pregnancy, caesarean section, post-term
delivery and maternal age 20–24 years (Table 1). Statisti-
cally significant variables were subsequently included in
logistic regression analysis. Seven risk factors remained
significant (Table 2). They are, in order of strength of
association:
1. Breech presentation: this increased the risk by an OR
of 24.3 (13.1, 44.9).
2. Family history: a positive family history of DDH
increased the risk by 15.9, if comparing the more
accurate study group data with the control data from
the Liveslot database.
3. Female sex: girls were 7.2 (4.6, 11.2) more likely to
have DDH than boys.
4. Other presentation: there was a small number of babies
in positions other than cephalic or breech, but their OR
was 5.0 and this was significant (p\ 0.027).
5. Vaginal delivery: breech babies are more likely to be
born by caesarean section, which explained the high
crude OR for caesarean section. Once this confounding
was controlled for, caesarean section was found to be
protective, and vaginal delivery increased the risk by
an OR of 2.7.
6. Parity: there was a decreasing risk of DDH with
increasing parity; first and second born children had an
OR of 1.8 compared to third and subsequent children.
7. Post-maturity: babies born after 38 weeks were more
likely to have DDH (OR 1.7).
8. Several factors showed interaction with the baby’s sex,
therefore the above factors were recalculated for
female children only. Five of the six variables
remained significant (all except ‘other position’) and
maternal age over 25 years became significant (Fig. 2).
ORs were recalculated for male children, and only
three factors remained significant (Fig. 3).
Fig. 1 Birth rate and DDH
prevalence over the study period
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DDH incidencewas plotted againstmaternal age and birth
weight, as they are continuous variables and have previously
been associated with an effect on DDH incidence
[1, 5, 6, 10, 11]. However, the trend in both variables did not
reach statistical significance (see Figs. 4, 5).
Within the DDH group a trend was demonstrated
towards higher parity (Fig. 6) and higher birth weight
(Fig. 5); the control data closely matched UK-wide data. A
comparison of head circumference and gestation for the
two groups was completed (Fig. 7), demonstrating that the
two match closely in both groups and that any effect due to
one may be confounded by the other.
Referral pathway and dysplasia severity
More in-depth analysis was performed on the study group to
assess why babies were referred (whether from the neonatal
examination, the 6-week examination, later detection or
from the presence of risk factors) and whether any pattern
existed between referral pathway and severity of dysplasia
(e.g., whether there was a greater readiness to diagnose mild
DDH in those with risk factors), as this could be seen as
evidence of measurement bias. The range of severity of
dysplasia was similar for babies referred via all routes, which
is against any notion of bias shown to one or other groups
(Table 3). A large proportion of those detected clinically had
associated risk factors in addition to the abnormal physical
findings. Almost all babies sent for US screening had the
associated risk factors of breech presentation or a positive
family history. A considerable number of babies diagnosed
late had risk factors, and should have been referred earlier
under our policy of selective US screening.
Table 1 Variables with
significant association to DDH
Risk factor Odds ratio (crude) 95% Confidence interval p value
Female sex 7.3 4.5–10.1 0.000
Breech position 8.6 6.1–12.1 0.000
Other position 3.49 0.86–14.22 0.063
Family history 12.6 8.9–17.8 0.000
First pregnancy 3.6 2.3–5.6 0.000
Second pregnancy 2.4 1.49–3.77 0.000
Caesarean delivery 1.72 1.25–2.37 0.001
Post-term delivery 2.32 1.58–3.40 0.000
Maternal age 20–24 years 0.46 0.26–0.82 0.007
Table 2 Variables with true
significant association with
DDH following logistic
regression
Risk factor Odds ratio (adjusted) 95% Confidence interval p value
Female sex 7.2 4.6–11.2 0.000
Breech presentation 24.3 13.1–44.9 0.000
Other presentation 5.0 1.2–20.8 0.027
Family history 15.9 11.0–22.9 0.000
1st/2nd pregnancy 1.8 1.5–2.3 0.000
Vaginal delivery 2.7 1.6–4.5 0.000
Born after 38 weeks 1.7 1.21–2.4 0.002
Fig. 2 Odds ratio for risk factors for DDH for female children
Fig. 3 Odds ratio for risk factors for DDH for male children
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Family history
Family history was analysed in more detail to ascertain
which relatives were most routinely affected (Figs. 8, 9).
Nine hundred and forty babies (out of 37,051 total live-
births) from the control group (therefore without DDH) had
a positive family history suggestive of a relative with hip
dysplasia, encompassing 1006 relatives in total. Forty-five
babies (out of 182 babies in total) from the treatment group
(therefore with DDH) had a positive family history sug-
gestive of a relative with hip dysplasia, encompassing 51
relatives in total.
Tables 4 and 5 present the raw figures and percentages
of the occurrence of DDH in relatives subdivided by rel-
ative type. An estimate of the likely number of relative
types per child was made (assuming mean 2 children per
family). In this manner the likely chance of a particular
relative type having DDH was calculated for both control
and treatment groups. Marked similarity was found in the
family pedigree for DDH risk in both treatment and control
groups with both demonstrating predilection for female
maternal-side relatives and in the following order—(1)
Fig. 4 Analysis of DDH
incidence relevant to maternal
age
Fig. 5 Analysis of DDH incidence relative to birth weight (cases,
controls and UK population)
Fig. 6 Analysis of DDH incidence relevant to parity
Fig. 7 Head circumference relative to gestational age
J Child Orthop
123
mother, (2) sister, (3) maternal aunt, (4) brother, (5) father,
and (6) maternal cousin.
Late presenters
The 34 children presenting ‘late’ (with 36 dysplastic
hips in total) had neonatal and 6-week clinical exami-
nations that were thought to be normal. They had no
additional risk factors (breech position or positive
family history) for DDH that would have warranted an
earlier referral.
Discussion
Regional incidence, screening and definition of DDH
The incidence of DDH in our region and the rate of Pavlik
harness application were within the accepted range [10–12].
Sonographic immaturity [13] and increased soft tissue laxity
[14] immediately after birth can lead to over-diagnosis of
DDH. This was avoided in our study by DDH only being
diagnosed in babies with Graf 3 and 4 hips, or in babies with
persistent dysplasia and/or instability after 6 weeks [1].
Fig. 8 Schematic for relatives
of babies from the control group
with a positive family history
for DDH
Table 3 Method of referral compared to associated risk factors and severity of dysplasia
Presentation mode Sex No. Positive family history Breech presentation Dysplasia (Graf 2a/b/c) Dislocated (Graf 3/4)
Neonatal examination Male 12 4 2 1 11
Female 80 16 24 8 72
6-week check-up Male 0 0 0 0 0
Female 10 1 1 0 10
US screening Male 7 3 3 1 6
Female 34 15 12 8 26
Late detection Male 3 1 1 0 3
Female 36 5 4 3 33
Fig. 9 Schematic for relatives
of babies from the treatment
group with a positive family
history for DDH. Asterisk the
total numbers of each type of
relative with DDH in the
relevant boxes
J Child Orthop
123
Table 4 DDH occurrence in relatives of the control group
Type of relative
(control data)
No. of children
(control data)
Average no. of relative
types per child
Estimated no. of relative types in
control group
Percentage of relative type
with DDH (%)
Mother 339 1 339 33
Maternal aunt 144 1 144 14
Maternal cousin 97 2 48.5 5
Father 55 1 55 5
Sister 50 0.25 200 20
Maternal uncle 33 1 33 3
Paternal cousin 30 2 15 1
Sibling 25 0.5 50 5
Brother 21 0.25 84 8
Maternal
grandmother
16 1 16 2
Paternal aunt 16 1 16 2
Paternal grandmother 7 1 7 1
Paternal uncle 7 1 7 1
Maternal grandfather 4 1 4 0
Paternal grandfather 1 1 1 0
Not specified 161
All relatives 15 1019.5
Table 5 DDH occurrence in relatives of the treatment group
Type of relative (of
children with DDH)
No. of children
(with DDH)
Average no. of relative
types per child
Estimated no. of relative types
in control group
Percentage of relative type
with DDH (%)
Mother 22 1 22 33
Maternal aunt 9 1 9 13
Maternal cousin 4 2 2 3
Father 3 1 3 4
Sister 5 0.25 20 30
Maternal uncle 1 1 1 1
Paternal cousin 1 2 0.5 1
Sibling 0 0.5 0 0
Brother 2 0.25 8 12
Maternal grandmother 1 1 1 1
Paternal aunt 0 1 0 0
Paternal grandmother 0 1 0 0
Paternal uncle 0 1 0 0
Maternal grandfather 1 1 1 1
Paternal grandfather 0 1 0 0
Not specified 5
All relatives 15 67.5
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Known risk factors
Our study confirmed that female sex, family history of
DDH, breech position and primiparity are major contrib-
utors to a baby’s risk of developing DDH. Moreover, it
quantified the odds of developing DDH if a baby is in
possession of risk factors, albeit with relatively wide con-
fidence intervals. This provides the potential to model a
baby’s risk of DDH based on the presence or absence of
these factors. Although oligohydramnios was not reliably
recorded in the control dataset, among the cases, the pro-
portion with oligohydramnios was reliably recorded, but
the control data do not allow us to comment on it as a risk
factor.
There is potential for measurement bias in our study
because those babies with a positive family history or in
breech position were routinely screened with US, as
opposed to those without. Thus, babies without these risk
factors and with only borderline/potentially low Graf-
scoring dysplasia that did not result in obvious clinically
detectable abnormalities, but which may have caused per-
sistent dysplasia (and subsequent later hip pathology such
as osteoarthritis), may have been missed. However, the
number of borderline cases was relatively small compared
to the number of more severe cases that should, if not
detected at an early stage, have a high risk of causing
symptoms.
Our study demonstrated extremely high ORs relating to
female sex (7.2 adjusted) and breech position (24 adjusted)
compared to that traditionally quoted in the literature.
There may be an element of selection bias responsible for
the latter, due to those in breech position routinely under-
going US screening; however, the wide confidence inter-
vals suggest that chance may also be a factor.
Other risk factors and theories of aetiology
Our statistical analysis shows that the second born child
has an increased risk of DDH—less than the first born, but
still higher than the risk for subsequent children. This has
been found before but not widely publicised [6, 15].
‘Post-maturity’ has previously been suggested as a
potential risk factor for DDH [10, 11, 13]. Our study
confirmed that babies born after 38 weeks gestational age
were indeed at a higher risk.
Our study demonstrated a correlation between higher
birth weight and a higher risk of DDH in a dose–response
fashion. This has on occasion been demonstrated previ-
ously [14], although it has more often not been replicated
in a number of smaller studies, probably due to a lack of
statistical power.
These three ‘less conventional’ risk factors are all
plausible if one accepts the theory that DDH is related to
‘packaging disorders’. This theory suggests that it is tight
constrictive conditions in the womb that lead to malposi-
tion of the hips, and subsequent DDH [5]. There is evi-
dence that the hip becomes particularly lax for a short
perinatal window, which may be an adaption to allow
delivery through the birth canal [16].
Maternal age had a significant trend effect on incidence,
but the effect was complex. Mothers aged 20–25 years had
the lowest incidence, with incidence rising with increasing
age over 25 years, but there was also a slight increase for
mothers aged\20 years. One could postulate that this may
be due to relative immaturity of the birth canal in very
young mothers, but it remains hard to explain the higher
incidence in the older mothers.
Difference in risk factors between the sexes
All the above risk factors remained significant when
analysed for girls alone. Subgroup analysis of boys only
showed significance for breech position, other (non-
cephalic) position and family history. It failed to show
significance for the first or second born child, post-matu-
rity, maternal age or high birth weight; however, as boys
were the far smaller group, it would be expected that this
would give rise to a lack of statistical power. It is therefore
probably unwise to draw strong conclusions from this
subgroup analysis.
Comparison with previous studies
Several studies have found increased risk with female sex,
family history, and breech position [17]. Some have not
shown these, presumably due to lack of power. A meta-
analysis of 28 publications failed to show a significant
increased risk for primiparity or oligohydramnios, but the
findings may have been diluted by including all studies
rather than all high-power studies [18]. The larger studies
tend to find more risk factors, with narrower confidence
intervals, which would be expected due to their larger
statistical power [5]. Although not perfect, our data con-
tained few missing or inconsistent data values, and our
statistical power, as evidenced by the low p values, was
considerable, and we therefore feel this adds weight to our
findings.
Discussion of caesarean section
Vaginal delivery and caesarean section have been investi-
gated before with conflicting results, probably due to a
failure to control for confounding variables with logistic
regression analysis [14]. We found with crude ORs that
caesarean section appeared to increase the risk of DDH, but
there was significant interaction with breech presentation
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and other variables. When these were controlled for, cae-
sarean section actually reduced the risk. In a large study of
the South Australian population, the same reduction in risk
for breech babies if delivered by caesarean section was
found [10]. This does not prove causation between mode of
delivery and risk of DDH. However, it appears plausible
that a vulnerable hip is more likely to be stretched or
become decentered during a traumatic passage through the
birth canal, particularly if in the breech position.
Theories of aetiology
Most authors cite two probable classes of causative factor
in DDH. One set, alluded to above, comes under ‘pack-
aging’ disorders with late gestational age, high birth
weight, high-tone primiparous womb, and abnormal posi-
tioning belonging to this theory. Congenital talipes
equinovarus and congenital muscular torticollis are thought
to draw their association with DDH from the same set of
causes [19, 20]. An increased risk from vaginal delivery
compared to caesarean section may imply a potential for
exacerbation of latent instability during a tight and trau-
matic passage of a breech baby through the birth canal. The
other major factors in aetiology are probably heritable—
ligamentous laxity, and a shallow acetabulum.
Proposal to modify the screening programme
by calculating risk
The risk to different babies varied by orders of magnitude
according to the combinations of risk factors, particularly
sex, family history and breech position. Thus, it may be
possible from our figures to calculate a risk for each indi-
vidual, with appropriate confidence interval, and to base
US screening on this risk. Deciding the threshold would be
the difficult part, and any proposed change would have to
be audited prospectively as results are not entirely
predictable.
It is worth re-iterating that any selective US screening
programme relies on good clinical screening of the
remainder of babies. Therefore, it is crucial if US is only
used selectively, that training of midwives, health visitors,
GPs and paediatricians is ongoing in the detection of risk
factors and in the technique of neonatal examination.
Conclusions
This study has reinforced what is known about certain risk
factors for DDH and has lent weight to the existence of
other, less known risk factors. The majority of risk factors
are compatible with a model of DDH which involves at
least one heritable element that is more strongly expressed
in females, a normal perinatal tendency to increased laxity,
and additional environmental factors in the womb and
during birth that may push a vulnerable hip towards dys-
plasia, instability and dislocation. This epidemiological
information may help inform health care planning and
screening policy. A selective US screening policy, as long
as it is based on sound clinical examination and risk-based
referral for US, can diagnose the majority of cases of DDH
[9], but a small proportion of cases with normal neonatal
examinations and no risk factors will still go undetected.
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